Published: 2/1/2022

(Shropshire, UK) – February 1, 2022 – Smithers, a leading provider of testing, consulting, information, and compliance services, has invested in a Gerstel Sample Preparation Station enhancing its Extractables & Leachables services. The Gerstel Sample Preparation Station enables Smithers to better serve pharmaceutical and medical device clients by decreasing human interaction and increasing precision.
 
By automating the sampling process, it helps reduce reporting times, improves repeatability, and enhances the limits of detection. In addition, the automation positively impacts the laboratory's environmental footprint, as it significantly reduces the volume of consumables used during the extraction procedure.
 
“Smithers is committed to investing in the latest technology to improve our clients’ experience,” states Gael Peron, Vice President, Smithers Medical Device Testing Division. “This new equipment enables us to continue to provide the most accurate data, on time, with high touch to our clients worldwide.” 

Smithers’ global support for medical device and pharmaceutical manufacturers includes:

• Device physical and functional testing
• Shelf life studies
• Transit studies
• Failure and technical investigations
• Extractables and leachables testing
• Material selection and evaluation
• Batch release testing

 For more information on how Smithers works with clients, please get in touch with our experts.

####
About Smithers:
Founded in 1925 and headquartered in Akron, Ohio, Smithers is a multinational provider of testing, consulting, information, and compliance services. With laboratories and operations in North America, Europe, and Asia, Smithers supports customers in the transportation, life science, packaging, materials, components, consumer, and energy industries. Smithers delivers accurate data, on time, with high touch, by integrating science, technology and business expertise, so customers can innovate with confidence.